Transcript for "From Scheduling to Reimbursement: Optimizing Your Pharmacy's Vaccination Workflow": Welcome to today's webinar hosted by EnlivenHealth. Today's webinar title is from scheduling to reimbursement, optimizing your pharmacy's vaccination workflow. Thanks for joining us today. Before we get started, I'd like to highlight a few housekeeping items. Please type your questions in the q and a tab to ask questions throughout the presentation. We'll be sure to answer your questions during the dedicated q and a session towards the end of our time together. We are recording today's webinar. The recording will be emailed to all those who registered. And now I'm delighted to introduce today's presenters. Jason Ausili is the senior director of solution sales and strategy at EnlivenHealth, where he's focused on delivering innovative clinical based technology solutions that help mobilize pharmacists as care providers and practice at the top of their license. Jason received his doctor of pharmacy degree from Butler University and his master of science in legal studies from Cornell Law School. He held a variety of roles across the spectrum of community pharmacy and throughout his career has stayed centered on the aim to expand the scope of pharmacy practice, improve health care quality performance, and ensure pharmacists receive equitable payment for clinical services and improving patient outcomes. Jameson Groot leads EnlivenHealth solution sales and strategy team for engagement solutions. With his background as a pharmacist, Jameson leverages his expertise to drive growth in pharmacy engagement, enhance the utilization of clinical services within pharmacies, and foster patient engagement through innovative technology solutions. Yun Chu is the senior clinical adviser at EnlivenHealth, where he supports pharmacy transformation and commercial growth initiatives by bringing clinical expertise and industry insight for product development, strategic planning, and customer engagement efforts. In his role, he helps translate the voice of the customer, advance clinical readiness, and drive the expansion of pharmacist provided care. Youn earned his doctorate of pharmacy degree from the UNC Eshelman School of Pharmacy and completed a postdoctoral fellowship in population health through Campbell University College of Pharmacy and Health Sciences and Omnicell. He's passionate about empowering pharmacists to deliver the full scope of pharmacist provided care, improving health care quality, and advancing innovative solutions that elevate the role of pharmacy in patient care. And without further delay, I'll hand it over to Jason. Alright. Thanks, Nikki. And thank you all for joining us today. We know how how precious your time is, and we really appreciate you dedicating this hour with us today. June is the time when vaccination planning really comes underway. So we're we're hoping that we provide some really timely information that helps you navigate the upcoming season. Granted, there's been a lot of changes and thing all the information is, dynamically changing. So our goal is to deliver the the most current information, up to date information that we can. But also, you know, as the headlines are evolving daily, our goal is to keep you informed and, you know, look for a future webinar in the July time frame for us to update you further. But nonetheless, our goal today is to really help grow your back grow strict. We're gonna be talking about, you know, that in the agenda slide. Ryan, if you can. So by by talking about, we're gonna start off by reading the EnlivenHealth mission and vision. We're gonna talk about some of the challenges that you're experiencing. The landscape the business landscape is difficult right now. We realize that. But there are some important tailwinds that are gonna help you navigate through this, including the upcoming respiratory vaccination season. Our ex resident expert in vaccinations, Youn Chu, is gonna take us walk us through what the what the upcoming vaccination season looks like, what we currently know, granted it's dynamically changing, but also what we can expect from across a few different categories. After Youn takes us to that section, we're gonna have a panel discussion. In addition to the tailwinds that are that we're facing that are positive, technology can really help streamline and automate your vaccination workflow to set you up scalable growth in the future. And then finally, we're gonna leave you with a little bit more information on Enliven Health solutions and how you can contact us, and then we're gonna dedicate the last ten to fifteen minutes for live q and a. So please do, as Nikki mentioned, document your questions, throughout the presentation, and we'll get to them at the end. Alright. Next slide. So starting off with our mission and vision, EnlivenHealth mission is to be the innovation epicenter, while health where health and care united the pharmacy. We're dedicated to transforming pharmacies by providing them with the digital capabilities to elevate the patient pharmacy experience, deliver exceptional patient care, and cultivate sustainable growth. We advocate for a role where pharmacy teams stand at the forefront of health care, empowering the practice at the top of their license, and aiding them with their commitment to patient care collaboration and continuous learning. Next slide. As we move forward, I wanna talk about the landscape a little bit. This is gonna be no secret to many of you or any of you. Right? I'm I'm basically preaching to the choir, But I do wanna leverage this opportunity to talk about some of the important tailwinds that we're facing, including the upcoming vaccination, season as a way to boost, you know, diverse clinical revenue streams. Next slide, Jason. So it's no secret that you all are facing the perfect form of financial pressures, labor shortages, and outdated technology. On the financial front, sales continue to increase on the prescription side, but we're but we're seeing, you know, 90% of all the prescriptions dispensed are generics, which creates a pain to discrepancy because that's only 11% of the revenue. Most of you are trying to expand the clinical services that you offer, but, you know, it's different from state to state. State's scope of practice varies and recognition as providers varies on that front as well. Not to mention, patient experiences are connected. Very few have a a a full 360 degree view of the patient, which which causes, you know, a bifurcated patient experience. And finally, growing workforce and operational challenges. We've all heard about the pharmacy closures that are happening across the country, and that's shifting work. Right? That's shifting vaccination opportunities to the the stores that remain open or the pharmacies that remain open. On top of that, although we're seeing employment opportunities increase, pharmacy school applications have gone down over the past decade. I know this creates a pretty big picture, but the good news is we have a very important tailwind tailwind that are are driving us forward. We have progressive state policy reform on both the scope of practice, the state's scope of practice, and pharmacist, provider status recognition front. We have consumer demand that's pushing people to expect convenient care closer to home at their local community pharmacy. And finally, we have public perception that's shifting. Pharmacies are no longer placed just to get prescriptions filled. The public demands getting more minor primary care services at their pharmacy. But that being said, we'll we'll shift into the next, slide. We'll start our panel discussion. I'm gonna kick off our panel discussion with a question. What headwinds are pharmacies currently experiencing specifically rate related to vaccines that could impact the upcoming vaccination season? And, Jameson, I'm gonna kick this over to you Yeah. Thanks, Jameson. And appreciate it. Yeah. What a what a week, I'd say, to, to kind of, kick this question off with. And, I'm sure if we had our our webinar on on Monday, we may be kinda thinking about this slightly different. But I'll I'll I'll start with some of the things that we've seen over the last, you know, number of years and and, you know, really since COVID and even maybe slightly before COVID. And I think again, you know, the obvious one here are some of the staffing challenges in the resource constraints that the pharmacies, experience and and and have dealt with now for, a number of years. High turnover, hiring, you know, training related issues and, you know, we we realize and we understand that that, you know, the challenges there lead to, you know, time consuming, you know, training, experiences for pharmacies, you know, costly. It bogs the pharmacy down. We understand, you know, hey. When you have to, train new folks and and and you have to having to do this, quite often, that can really, you know, really bug and tie down that pharmacy workflow. So that's, you know, that's that's really, you know, a tough one for for a lot of pharmacies now. When you look at, you know, pharmacy school graduation, you know, expected graduates from pharmacy schools. You know, I know that's that's been a challenge recently. Yeah, I read recently, you know, will be a few thousand short of of, you know, what we need from a graduation rate in 2025, 2026 to fill those roles. So that's, you know, of course, a a challenge that we would see. And I think the the the other one, and and it is spoken about some, but maybe not as often as that it should be, is really the value of technicians, and the impact they they play, you know, and and and, you know, really have on the pharmacy and the pharmacy environment. You know, really, they're the they're the engines of the car. You know, the pharmacist, a lot of time, is is you might be driving the car, but you need a a really solid group of technicians to, you know, to really make, your pharmacy run, but more specifically, you know, your immunization, process and and that side of your your business. You really need them to be a key part of that as well. And we see, as you alluded to already with some of the legislation changes, them becoming increasingly more, are becoming increasingly more impactful, to the immunization side of of the pharmacy business. So that's, you know, of course, that's that's one major area. I think evolving technology would be a key key area. You know, pharmacies are looking to digitally transform, you know, manual processes. You know, how do we go from the mindset of, you know, that traditional manual process of administering vaccines or even, you know, really any part of the business and digitize that or digitalize that process. And that's a that's a key, area that that, you know, is, it's a bonus. It's it's a plus, but there's also, again, some headwinds. And and I think a lot of that has to do with how how do you identify the right solution. It's it's an evolving it's a changing market, and and there's a lot of new solutions. And and how do you identify that one that really works for you, and and helps you enhance your immunization practice and your immunization business? And then also with that is how do you implement those solutions? How do you get buy in from your pharmacy staff? How do you get, you know, engagement from those inside the pharmacy, and and even market that to your patients to have them buy into different processes, you know, whether it's, scheduling a vaccine or filling out you know, your consent form ahead of time, which I know we'll talk about. So, you know, those are some important key, you know, areas from a a technology standpoint. And then again, you know, as I alluded to, you know, from this week is some of the changes that at the, the federal government level. Whether it's, you know, the CDC and some of the guidance that they're providing, or again, some of the the recent, you know, news on on Monday evening with, the changes with ASIP and and all all the members, you know, being removed and and being replaced, prior to their, you know, their upcoming meeting at the June. So again, from from what we know at this point, it seems like that meeting still is is going to happen. We we do not yet know who will be, you know, on the committee at that point. But, of course, you know, those changes will have, you know, potentially an impact on, immunization business, immunization practices moving forward. So I think it's an area that's that's, you know, key to, key to, you know, keep an eye on. You know, we saw at the May, CDC made some changes with with some of the the COVID vaccines as far as pregnant women and and, and children, pediatric the pediatric population. And, you know, even some of the stuff that was said and what was, you know, put on the CDC website, I think there are some discrepancies there. So there's, again, it's it's, you know, really dynamic right now as far as the changes that are happening, the changes that that could happen. And and we really don't know, you know, what that all means at this point. And I think, you know, when you think about trickle down effect and and what what impact that could have, not only just, you know, who is is required to get a vaccine, who is, you know, thought that, you know, they should be receiving a vaccine as far as patient populations, but, also payers. You know, when you're you know, you talked about pharmacies have have increasingly become a crucial part of the the immunization, community in in, you know, really the entire US. We see, you know, continued, expanded, legislation. You know, if we do see changes, we see, you know, populations who maybe immunizations aren't recommended. You know, maybe it's more of the shared clinical decision making. You know, there could be changes as far as payers covering vaccines as well. So, you know, I think there are a few things that we wanna really focus on and really look for, you know, over the the next coming weeks, especially that ACIP meeting coming up and see what, you know, changes there may be and and certainly some of the trickle down effect that that could come from that. Yeah. Well, thanks, Jameson. It really is, there's a lot of unknowns. Right? And, I I want the audience to rest assured that we got a group that's staying on top of this. We wanna be thought leaders and deliver information as currently and, based on as fact as much fact as possible. So as I mentioned, we will have a follow-up webinar, when we turn the corner into the next month and that ASAP group has had a chance to meet. So please do, leverage us as your thought partner thought partners in the industry. Youn, how about you? Do you have anything to add to what Jameson, just shared with us? Yeah. So I echo what Jameson mentioned, but I think another barriers or I just had witnessed the the unfortunately, a lot of communities, has been impacted by the recent pharmacy closures. So that put additional pressure on pharmacies, existing pharmacy for providing vaccination service because now they have to manage not just prescriptions, for the new patients, but they have to prepare to provide the vaccine services for the upcoming flu seasons or other routine vaccines that patient may need requires. So that's another headwind. And, Jason, I know you already mentioned the the change in the enrollment for the pharmacy school, and there's a drop noticeable drop in the students pursuing pharmacy at the field. So that is another headwind. I know some pharmacists, are precepting students or taking interns during the flu season. It's to help out with managing the flu vaccines, for their community members. So not having enough students or interns can potentially have a negative impact on the community as well. And and James noted it mentions that there's a confusion regarding the CDC recommendations and federal guidance on the COVID nineteen vaccines, so they kinda create a confusions in the publics and also the the health care providers. So that's something that we need to monitor closely and then navigate, this year, which is, we are getting new patients that every day and and try to monitor as much as possible, but, this is something that is, is common landscape of vaccines. Great. Well, thanks, Youn. That's a good transition to that section. In this section, we're gonna have, Youn Chu. He's our vaccine vaccination expert who literally attended every ACIP meeting throughout the pandemic and beyond. So he's been tracking us so closely, and we get to hear from you. What do we know? Or at least what do we think we know, currently about the upcoming respiratory season? But, also, how do we help you see around corners? What could happen as we look ahead at these uncharted waters based on some of the information that we know? So, Youn, I'll I'll I'll let you take it over from here for the next few slides. Okay. So I can definitely share what I know so far. There's a lot of uncertainty as you mentioned, but, I can share what we know so far. So the FDA actually provide a recommendation for the up updated flu vaccine not flu, but COVID nineteen vaccine formulations in May. So it's gonna be monovalent vaccines like, for the for the next updated, I guess, next, COVID vaccine season. Oh, it's not really season. It's, you know, vaccine per se, but, but, so it's gonna be targeting the n one lineage, specifically the LP 8.1 strain, which is the common, dominant strain circulating in United States and Europe. And the FDA also approved the two new vaccine this year. So Novavax COVID nineteen vaccine officially got the name, so it's called, Nuvexavoid. Hope that I'm pronouncing it right, but, this is approved in May nineteen of this year. And then the updated Marmee vaccines that did all by Moderna, which was approved in May. So it's a and next spike. So these are the two product approved, available in United States, and they're indicated for sixty five years in order. And, also, this can be used in the, people with 12 between 12 to 64 with risk factors, with certain conditions. And if you look at the CDC, guidance for for qualified to receive these vaccines, they're they basically result any conditions. There are a lot of different conditions. So it's it's like diabetes, heart disease, mental health conditions, and immunocompromised condition. So the most general population is likely have a at least one of this condition and qualify to receive this updated vaccine. Alright. And the damage still did mention in the previous slide that, there's some change in the guidance, in May May at, the Department of Health, Human Health Service announced that COVID nineteen vaccine is no longer recommended in children's and pregnant women's, and the CDC actually did update their, pediatric schedule to reflect the changes, but it kinda created changes because it seems like it's contradicting the previous guidance. So that's, what we know about the COVID vaccine so far. And going to I'll change the topic to influenza vaccines. There's not a significant change in influenza vaccine per se, but, but there's a new product. It's not really a new product, but there's the, the OT OTC product for the flu vaccine is approved in 2024, and it's approved missed. So it's indicated for people, between two to two forty five 49 years old. So, that's still kinda new, but, for just general recommendation, there's a little significant change, for flu vaccines. But, there's some change in the RSV vaccine world. So I think most people probably heard that, CDC actually provided guidance, on RSV vaccines, in late last year. I think they updated, the age targeting age to 75 year and older. Historically, it was a 60 in order, but, they actually, modified the recommendation to 60 to 74 for high risk conditions and 75 in order for everybody. So there's a significant change. And the ACIP group actually met earlier this year, and they wanna further reduce this number to fifty years in our orders. So, like, there were the high risk, conditions. So there's something that we need to monitor for. It's not official yet. We are still waiting for CDC director to make official statements whether or not, adults between 50 through, 74 are born to receive the, 50 vaccines. Currently, the recommendation is still 60 through 74 for a risk condition and 75 and older or all, other populations. Alright. Next slide. Alright. So outside of, the respiratory vaccines, there's another bag of some other non respiratory vaccine update, so the pneumococcal vaccine age expansions. So it's the CDC actually made a recommended modified the recommendations, October of twenty twenty four to reduce the the minimum age to 50. For the pneumococcal vaccine, historically, it was 65 in order. So this is a definitely expanded eligibility for the dose who qualify for pneumococcal vaccine this year. And there's another, vaccine approved this year, it's called pNEMBI. You you guys may heard this, product. It was actually approved in February of this year, Valentine's Day, February 14. And this is a pentavalent manageable cocktail vaccines, developed by GSK. This target of five different serotype. So this is the one. Actually, the one was approved in 02/2023, and this is the pen, Pembrya, developed by the Pfizer. So this is, definitely welcoming addition to target the meningococcal disease, And this is, for the people who were qualified for meningococcal vaccines, but they don't wanna receive the two different type of vaccines, men b and the mena, a b the ACY ACWY. So this is that kind of combo vaccine that's available for, the population between the 10 years to 25 years old. Next slide. So what could happen ahead? So I already kinda eluded a lot of information from the previous slide. So there's a lot of uncertainty, but, there are speed vaccine eligibility, can potentially expand to target 50, to 50 years and older. So between this 50 to, that 50 and orders for the upcoming record seasons. We still need to wait for the direct CDC director to make final decisions, but that this could increase the eligible population. And and even new products for, the flu available for over the counter. So flu mist is kinda interesting one, because it's a live attenuated vaccine, so not everybody's gonna be eligible for receive this vaccine, especially if they're immunocompromised or have, like, severe asthma, then the fullness may not be the right vaccine to receive. So we definitely have opportunity to educate patients regarding this product. And and also one thing to, think about is, like, OTC vaccine may not be covered by insurance because this is not a prescription if it's OTC, then it's not prescription. So, most likely, patients won't have insurance cover their vaccine. So we just probably need to think about, like, educating patient about how to administer this vaccine, but also the coverage for this type of accident because this may not be covered and patient have to pay out, pocket for that. Other uncertainty is regarding the the global trade and supply. I know you've heard of tariffs, like, on a lot of different things and a lot of different topics in the last couple months, but this can also impact impact, the trumps and also the vaccine as well. The syringe of vaccine supplies and needles can potentially subject to tariffs and also the, like, the active ingredients for the vaccine. So that can potentially increase price of the vaccines and also the delay, of the shipments and and, can potentially create a shortage. So this is kind of big unknown, but, we definitely need to monitor for changes and update from, the federal level. And the COVID nineteen guidance remain dynamic. There's a lot of unknown. Jameson already mentions, there's a this this Monday, there's a big announcement, from the, the media that the ACIP crew's been, dismissed, and they're recruiting the new members. So this is, creating a lot of, confusions and, and potentially delay the guidance from the CDC on the COVID nineteen vaccine recommendations. So, there's a lot of uncertainties, but I believe the pharmacy will continue to serve the key health care provider to help patient make the right decisions for their, routine vaccines including COVID nineteen, because they're gonna look look ask a lot of questions. Right? They may not know the answers, and they're gonna see the health care providers. And I think Bronx is gonna serve as a key, shared clinical decision making partner with the patients, in this upcoming respiratory season. Great. Thank you, Youn. Let's hop to the next slide. So now thinking about all the unknowns. Right? We we've shared some of the things that we believe to be true as of current, but how do we leverage how do we leverage some of these things, you know, to for growth? What are some of the ways pharmacies can leverage recent changes to grow their vaccination businesses? Youn, I'll start off with you on this one, and we'll we'll pop over with Jameson. So yeah. So I think there's a lot of unknown, but I think what we know so far is now there's more vaccine available, now than ever. Right? So pharmacies can administer not just flu or COVID vaccines or active vaccine, but they can based on the depending on the state, they can administer many different routine vaccines. So this is a great opportunity for pharmacists, and and a lot of patients are most likely eligible to receive more than one type of vaccines. So so I think leveraging technology to identify what's who is qualified for what vaccines and optimize the the appointments. Right? So scheduling software is gonna be the essential in this kinda, way kinda, improve the efficiency So if the patients are eligible for the flu, but also they're eligible to RSP or other kind of routine vaccines and manage a managed a couple of vaccines, the pharmacist can help with that and, utilize this skipping software to, maximize that opportunities and, also, to send a reminder, like, to the patients so that they are actually keep up with their appointments instead of forgot about their appointments and then, missing opportunities, because that often happened. It's a it's a bit of schedule sometimes that people get to check their calendars, and they might not remember they actually made appointments or appointments made by the family members. So that could potentially create a a missed opportunity. So any reminder, Eugene's, software, scheduling software would be essential. Great. Well, thank you, Youn. Hey, Jameson. So what are your thoughts on how can pharmacies leverage the current current climate to really focus on growth and scalability scalability for this upcoming season? Oh, I think you're on mute, Jameson. Apologies. Jumping off kind of what what Youn had had, started off with there with, you know, there is a growing number of vaccines. There are, you know, a growing number of opportunities. There are expanded, you know, folks that are eligible for vaccines. You have a lot of opportunity come come, you know, flu season when someone comes to get their flu vaccine to expand, you know, what else you can potentially provide for for those patients. Again, you you think about, you know, pneumonia and those expanded, you know, age group or that expanded age group from 50. You have, you know, you know, a whole group of patients who are who are coming to your pharmacy that are, you know, in that 50 64 range, coming for their flu shot, there's a good chance that they may not have that pneumonia vaccine. So, you know, engaging those patients and communicating those patients with with updates. So, you know, there's there's a lot of opportunity there. So, again, you know, it doesn't just sit on the pneumonia vaccine. There are other opportunities as well as shingles, you know, RSV, of course. So, you know, we'll kind of talk about the flu plus one or flu plus two opportunity where you, you know, you have a patient at the pharmacy. You look you can even look at your schedule in advance of of, you know, patient coming to the, to the pharmacy. So, you know, the night before that, identify, hey. Who are the patients that you potentially could, could receive another vaccine or an additional vaccine as well. So I think that's important. And then as as you said, you know, kind of on our, you know, looking ahead slide, and and kinda talk specifically about COVID nineteen, and it's been, you know, a topic of discussion so far is is there's a lot of changes. There's a lot of, you know, potential changes. You know, not a lot of people know what's going to happen with recommendations, opportunities, you know, what what's gonna happen over the next few months, and and pharmacists play, you know, really a key role in that in educating patients. So I think you're gonna have a lot of patients who, you know, if they read the news, if they're aware, they'll probably be somewhat confused. Hey. You know, what does this mean to me? What does this mean for me? You know, what am I really eligible for? What should I be getting? And and, you know, I think there's a great opportunity to for pharmacists to really fill that that void in that role. Yeah. That's great. I mean, that highlights the special and unique role that pharmacists has with their communities. Right? And and driving and building that loyalty and trust goes a long way. I think, you know, in many ways as pharmacists, we are stewards of education in our communities. And that that identifies a really a real really key point, Anderson. Thank you. Alright. Moving forward. Let's go to the next slide. We're gonna be talking about now that we've heard some of the headwinds, but also the tailwinds from a, you know, progressive state policy perspective, but consumer demand and public perception, and some of the opportunities to actually leverage the current climate to grow and scale your vaccine business, we're gonna shift our focus a little bit to how can technology automate, streamline, your pharmacy vaccination workflow to enable greater growth and scalability. And we're gonna break it down into before the patient visit, during the patient visit, and after the patient visit because it lends itself well to different techniques and and and technology strategies that you can leverage to drive automation with the goal of freeing up time so that you can see more patients, so you can treat more patients, and, really investing that time into growing your vaccination business. So with that being said, we're gonna go to the next slide. I'm gonna ask the question, how can technology help automate the previsit experience? And I'm gonna go back to you, Jameson, for this one. Yeah. No. There's there's there's, you know, a lot that can can be done, you know, in advance of that patient coming to the pharmacy. You know, we look at and I kinda think about three different buckets. One is patient identification. You know, what are the opportunities that a patient can, you know, be eligible for may be eligible for, you know, we just, yeah, just talked about, you know, prior to the, you know, to the patient coming to the pharmacy for their flu vaccine, you know, going through your schedule and seeing, you know, hey. You know, these 10 people scheduled vaccines who may be eligible for an additional, immunization or other services, of course, as well. And so, you know, having a a work queue for that, having a way to document, hey. I've communicated with this patient. This patient has received, you know, this vaccine. You know, I think these have been challenges in the past, you know, for pharmacists. You know, just making sure that they're spending their time efficiently identifying these opportunities versus, you know, every month you see the same person who's filled, you know, you know, asthma inhaler and you're like, should this patient get, you know, a pneumonia vaccine or it's a, you know, patient who's, you know, 70 years old and you're trying to identify if they need a shingles vaccine. And so, again, streamlining that a little bit easier so that instead of, you know, doing that on an individualized basis for your patients, you're working off of a queue, you're working off of some form of of documentation, and and guidance. And I think that can be really useful, you know, from a patient identification perspective. And then on top of that, you wanna make sure that your outreach and your communication with that patient is is efficient, and effective as well. So, again, that could be at the pharmacy. That could be, you know, patients at the pharmacy I need to communicate. That could be picking up the phone, you know, saying, hey. I need to call this patient and and, you know, check-in with them. It can also be, you know, sending messages, sending an SMS text message, you know, finding, you know, hey. These 15 folks are eligible for a shingles vaccine. Let me send them a message, you know, so I'm not picking up the phone 15 times. Let me just send them a message. Let them know that they're eligible. Maybe I can, you know, put a put a link to my scheduling solution where they can just quickly go on and schedule. And, you know, that allows you to to really grow and and communicate, at scale with your patient base. So again and and again, it's not just, you know, shingles vaccine. It could be other opportunities, flu vaccine, pneumonia vaccines, really, again, any any type of of clinical service. So, you know, that's really important as well. You you know, you can identify those opportunities, but if they're not communicated efficiently, effectively, again, you're gonna struggle to, you know, to to potentially grow your your organization business. I think on top of that is also a little bit of a marketing piece as well. Just making sure again that your your, you know, your patients, your staff, you know, everybody's aware of what you're doing, you know, your your capabilities, how you are, you know, providing immunizations to the community. And then, again, the last bucket I would say is, you know, you've you've, you know, you've you've identified the patient. You've done that outreach. Patient's interested, as I alluded to, you know, embedding a a scheduling link, but getting that patient to, you know, potentially schedule that that immunization ahead of time and gather consent, gather that information that you need prior to the appointment so that the patient shows up, got their insurance, you've got their, you know, what they're they're looking for, and you can really smooth that process out from a a patient experience and even from a pharmacy experience. Again, you know, that's really important to this process is is, you know, making it easier for the pharmacy, making it easier for the patient to come in to get their immunization. A lot of that can be done prior to the patient even stepping into the into the pharmacy. And again, you know, as far as capturing that information, you know, you can capture whatever you want. You know, that's that's the the great thing about, you know, a lot of these solutions and and, you know, a lot about the, you know, pre visit experience for a patient is really gathering whatever type of information you need. So, you know, that's that's really an important piece of this as well. And, you know, again, I I go back to, to my days. And and for me as a pharmacist, you know, nothing was better than understanding, you know, my, my next day or even my current day as far as when patients are coming to the pharmacy to to get vaccines, you know, following a schedule. I know, again, it's challenging sometimes to to get folks to schedule, but from a workflow perspective, from an anticipation perspective, it it really was a help for me, and and really a nice guide so that I wasn't, you know, getting as surprised. Of course, there's always gonna be a walk in flow. But but, you know, there wasn't as of a of a surprise when, you know, maybe a couple of folks came in to get there for the vaccine. So, again, I think there's, you know, a lot of different a lot of different areas that we can act on ahead of the, ahead of the patient going up to the pharmacy. You know, again, including the identification, communication, and then, you know, capturing all that information ahead of time. Great. I mean, one of the superpowers of pharmacy is there is our accessibility and convenience. So the walk in visit, you know, we don't want that to go away. But the more we can shift to proactive versus reactive vaccine experience, All these things can really help drive automation and and capture that not only the outreach part, but capture all that stuff before the patient comes in so they really stream streamlines, and, really creates the growth path for pharmacies to do more vaccines per hour. If you're just focused on vaccines for a chunk of time, wow, can you really do some, some good good business on the upfront. So now you moving to, let's move to the next slide. So now the patient has scheduled their appointment. They're about to come in. They arrive at the pharmacy. Can you talk about how we can automate let's flip to the next slide, please. How we can automate the, in you know, once the pharmacy arrives at the visit, how how can we automate that experience, Youn? Thanks for the question, Jason. So I think bringing the digit, I think, is its automating process can be important, especially at the Digi Pharmacy, with with, post offering a scheduling software, but, but have a scoring software, but it's anticipated walking. I think having to work your management would be very important to prioritize certain patients, especially the those who are have appointments or do for the multiple vaccine during the same visit. So having the workflow management software is gonna be essential and to help with the deep driving efficiency and manage, populations in the community. And also having the encounter template or documentation tool is gonna be essential for the standardization purpose, but also, the recent changes in CDC guidance, some of the vaccines are required here decision making, between the patient and the, providers. So having the documentations why patients are eligible for certain vaccines can be very important for the insurance purpose. So the encounter template is definitely accommodate, documenting why patients are qualified for what vaccines and having that records gonna be carry on to the next, and the patient profiles can be important for the future visit as well, and maybe patient can be really qualified for the other vaccine that, based on the documentation. So, the encounter template is gonna be important tool as documenting additional information that we may require to capture for the vaccination eligibility. Thank you. We all learned in pharmacy school if it didn't get documented, it didn't happen. Right? So having that having that really, important trail of standardized information that was documented during the patient care experience is always important even with vaccines. Alright. So moving forward. Next slide. And and so, I'm gonna talk about how technology can streamline after the patient visit. There's certain things that don't have to be done when the patient's right there with you. So when you think about how you divide your time, let's automate and streamline the post patient visit experience by by leveraging medical billing and vaccine registry reporting. Next slide. So a lot of manual time is spent, just entering, you know, going to the different state, you know, vaccine information system jurisdictions and entering the the vaccines manually can be a workflow burden to pharmacies. Why not save that time through an automated vaccine registry reporting solution? The time saved there can be reinvested in scaling and growing the vaccine business. So what technology can do is make that only a click of a button. Right? We we we we get a data feed. We know everything that happened. So why not let us, leverage our automated and electronic communication to report that vaccine for you so that you could spend time more time with the patient and more time, managing vaccine appointments and walk ins? Hugely important is getting paid as a provider. In order to get paid as a provider and not a dispenser of services, you need a medical billing solution. And we help pharmacies not only ensure accurate claim information, but make sure that they get paid optimally for the services they're providing. We wanna get paid the same way as MDs, DAs, MPs do. Right? We are providers on this front. So leveraging the medical billing solution that automates that process but also helps you track claim status is critically important. And finally, we're able to help you on value based care, programs as well. If you if you're working with clinically integrated networks, leveraging, you know, CPSN as an example, you can document in the same care experience. You could send, you know, the same documentation you're being sent on for value based programs or medical billing fee for service claims. So streamlining that process is really important. Next slide. This is where we bring it all together. And EnlivenHealth has, streamlined end to end clinical workflow that combines all these pieces that we just discussed, from identifying the right patient, patient, opportunities and from the patient population, how how often do you you know, how easy is it to know if somebody got their shot of Shingrix but not their shot? Without leveraging technology, that's very difficult to manage. But once you get, you know, a quick list of these patient opportunities, you can then send them an automated campaign that allows them to to a group of patients that qualify, that allows them to quickly and conveniently schedule a a personalized appointment at your pharmacy. Capturing all that information before they come in for the visit, wow, that's gonna save time. It's gonna save time, you know, the lines that they will call waiting for their visit. You you can get consent. You can basically generate all the information needed for the vaccine information statement of crime, without waiting for the patient to provide that info as well as their insurance information. During the visit, Youn talked about upper, organizing and prioritizing the work that needs to be done. If you've got a bunch of appointments scheduled scheduled, you need to make sure you have your staff here, to to cover those blocks of time accordingly. That's what the beauty of scheduling allows you to do. It allows you to make sure you have your inventory and staff aligned with the patient with visits that are coming in. So that prioritization is key. But also making that documentation process an easy button is really needed for pharmacies, and that's what we've done with our encounter templates and and allowing pharmacies to customize templates to meet documentation protocols. But then after the visit, you know, let's streamline, automate vaccine register re register reporting, medical billing, and submission of value based care programs. So at the end of the day, you're getting maximum ROI, while while leveraging automation technology to get you there. Next slide. Let's quickly talk about our AmpliCare clinical solution. This is the, this is the clinical workflow that helps target recruit patients. It helps personalize those communications that Jameson has talked about by sending out, you know, SMS text that won't keep the appointment scheduling and the consent form process. We also organize and prioritize the work just like I mentioned in the end to end clinical workflow. But the bottom line is we're integrated with our medical billing solution as well. So having one workflow to dot to identify, send outreach, schedule appointments, document, and bill, and then report to registries is critically important to have that one solution that does everything for you. Next slide, be remissed if I didn't double down on the reimbursement opportunity. It's critically important we get you paid as a provider so you can grow and scale your vaccine services to other services as well. That's what's gonna really be, you know, that diversified clinical revenue that's gonna help help you have happy and healthy businesses moving forward. With our medical billing products, we have years of experience, you know, processing medic medical claims of all types across all payer channels, whether it's Medicare, Medicaid, you know, or commercial, or private insurance. We wanna, you know, help you get paid and set up appropriately with the various channels of payers in your in your in your community. Next week, we wanna help you keep track of your billing and payment. Right? So we are we're helping you check claim status, denial status, and and having a clear view of what claims might be aging. And, you know, we're gonna help you hunt those down if you if you reach out to us for free. So having a partner there that is gonna help you ensure you get paid is critically important. Finalize optimizing those reimbursements. Right? If you, you know, you might be getting, many claims on the prescription side that could be sent on the medical side. We wanna make sure you're getting paid as a provider and getting optimal reimbursement for the services that you, provide. And then finally, we wanna this should not be a manual process. Right? No one wants to complete a HIPAA 1,500 form. Let us do the groundwork for you and make this, a really, really ROI driving experience. Final slide before we cut to q and a. It looks like you've got just about ten minutes left, so plenty of time to answer any questions here. Please do continue to enter your questions in the q and a box if you haven't done so so far. As a follow-up, in just about a week, next later next week, we're gonna host a follow-up session here where you can where you can dig in a little bit further. We're gonna have some folks showing you, a more guided walk through of our solutions. So you can sign up for this info session by clicking the scrolling banner at the beginning of your screen, to get more direct, guided walk through, in what you saw today or what you heard about today. Now we can we have an opportunity to show you in a more a little bit more detailed fashion. So hope to see you next week, as we have the clinical solutions and your pharmacy guided walk alright. I'm gonna cut the questions now. Give me just a while I pull up the questions box. And I'm gonna good. Oh, we got a great information here. Great questions here. question, what information do you have on the new pneumonia vaccine, CapVaxxiv? You and I know you're you're you're a vaccine, expert here. Do you wanna take that one? Is there anything you can, provide this, this attendee about the new what information you have on the new pneumonia vaccine, CAPVaxxiv? You and I think you might be on mute. Yes. I'm I think can you guys hear me okay? Yep. So Capaxev is, that is, PCB. I believe it's, yeah. I get kinda confusing confused with the, the abbreviation because there are so many different pneumococcal vaccines available. I think it's still, like I think it's '20 one is the PCV twenty one. So this is kinda updated versions of PCV twenty. So that is the kinda new and kinda enhanced, products available at this time. And I believe the CDC is still making changes to incorporate this, products into their guidelines. So more to come, but I know that this is kinda enhanced. There's one more so it's a PCV 21. That means it's have a one more serotype including the coverage. Yeah. Just got an addition on that, Jason. Yeah, I know the the CDC A SIP has has looked at that and and, looked at PCV twenty and Previnar versus Capaxev and and, yeah, to date, you know, they haven't said, you know, or or favored one in the, you know, one or the other, you know, from any any guidelines or any recommendations. So they're, you know, they're still viewed equivalent, as far as, you know, what the the the CDC and and ACIP has said, in the past. Yeah. Great. Okay. Next question. There's two questions that are related, so I'm gonna try to combine them. Can billing for provider administer specialty medications? Can that happen? I think it's under Medicare part b. And can we help with billing for specialty administered specialty medications? I'll I'll take this one. And the the answer is yes. We see a growing trend in pharmacies that are becoming, you know, accredited for specialty at retail, and those pharmacies absolutely are able to bill, the j codes. Right? Those are the HCPCS codes for the specialty products, through the medical billing platform. Now, obviously, that might vary by payer contract, but, yes, the general answer is, yes, you can bill, leveraging medical billing software for the j codes that are aligned with, specialty medications. So great question. Let's move on to another question here. Got another question. How do I find out what vaccines I'm authorized to provide in my state? So I have a two a dual response there. Well, if you are our our partner at Syncora, we've developed a great tool in in partnership with Syncora that helps, identify, state's cover practice and reimbursement opportunities. But always, as my recommendation in in working with your state pharmacy association, they're always going to bat for you at the, at their state level. And, you know, there are great references and resources on what those rules are regarding, you know, vaccinations. There it can be complicated, right, based on are they ACIP recommended vaccines only? Is there a specific age range for specific vaccines? For example, your state may have well, you can vaccinate three and older for the flu vaccine, but only adults for all ACIP recommended. It's important to know that combination in your state. Now I'd say always leverage your state pharmacy association resources, but also if you have, if you're in a state where there's an active, you know, clinically integrated network, like like CPSN, those folks are always great resources too when it comes to understanding what's reimbursable and how much you could get reimbursed you know, for administering vaccines in the state. Jameson, are you in anything to to add about, you know, the state based opportunity for vaccines? No. I was just gonna say, you know, going back to to, you know, your introduction and some of the the tailwinds, you know, we've seen over the last few years and and beyond that, a lot of positive momentum on the state level for for vaccine administration. And it it changes often. And so, you know, staying up to date on that is is really important, whether it's, you know, checking once a quarter or, you know, you know, couple times a year. But it's important. And and, again, you know, we're we're talking mainly on vaccines, but really all different types of services that that pharmacists can provide. But I think staying up to date on that is is really important and really key to this. And and it's, you know, it's it's, you know, whether it's, you know, the tool that a lot of health has with EnlivenHealth or it's, you know, staying up to date with your state association. It's, you know, a pretty easy thing to to do, to track that. That's great. What's interesting? Another reason to check is actually the Board of Pharmacy as well because they periodically update, and provide announcements or if there's a big changes. So definitely check out the State Board of Pharmacy website and FAQ. I see there's a section on the immunizations. That's a good resource to check. Great. Thanks, Youn. It looks like we got another question. It might be our last question. Let's see here. Do you know what vaccines can be billed to part b for better reimbursement? That's a great question, and I'm gonna break it down a few different ways because there is a standard. CMS has published information even if you do a quick search on, you know, which which medic which vaccines are built to part b versus part b. CMS has created a great document, a guideline for pharmacists on that front. But there are four four vaccinations that get billed directly to Medicare part b on the medical billing side, and those are flu, COVID, pneumococcal, and and the, hepatitis vaccine. So other vaccines like shingles and and others do get billed on the part b side, but it's important that you fully leverage those, the medical billing opportunities for the four that do go through on the medical side, because that is the primary pathway. Now on the Medicaid side, we're seeing a progressive trend where Medicaid has been recognizing pharmacists as providers at the state level. So even in the Medicaid realm, pharmacists may have an opportunity to submit vaccines, through medical billing versus prescription billing. It's important that you, you know, that you, research your your state Medicaid and MCOs, the guidelines on that front to understand, you know, are you enrolled as a provider who can submit vaccines to to Medicaid? If so, that's a great channel, to go down, from a from a provider perspective versus, submitting them on the pharmacy side. And the same really holds true on the commercial front. Commercial contracts are between the provider and the commercial health plan, so there's not a lot of published data on on that front. But I would say that, you know, you you are in control of negotiating those contracts with health plans. I would say start with the ones that are most predominant in your in your geography. Maybe there's just one or two commercial plans that make up a good percentage of your patient population. And then call the provider line. Right? Not the pharmacy line. That that can be confusing upfront. Ultimately, some sometimes when you call into the health plan, they try to oh, your pharmacy, I'm gonna push you over to the PBM. But this is different. I think now is the time to really get in and aggressively, you know, look for opportunities to get recognized as a provider. And if that means creating a new contract with a health plan that's that's big in your area, that's gonna be the next best step. So we're just one minute left here. One last question. We have time for one more. What portion of EnlivenHealth offers auto campaigns? Well, that's a great question. So what we showed you today, the AmpliCare clinical solution has, built in auto campaigning, as well. So not only, can you identify patients from your patient population who might qualify for flu, pneumococcal, COVID, etcetera, we we allow the we can we can also set up auto campaigns in addition to the into the, automated outreach that that are based on, you know, patient identify patient opportunities that we've identified from the data. So that is the same platform. We do have other robust patient engagement solutions, but I wanted to stick with what we've covered with you today. Auto campaigning does exist within within Amplicare clinical solution. Any last thoughts, from Yoon or Jameson before we cut? I'm right on that. Alright. Well, hey. I just wanna say thank you for all that you do. Your time is precious to spend an hour with us. We're always appreciative, for the the time, the commitment, the great questions. We will be back in touch. Not only will we share this video recording, we're gonna have a follow-up with, follow-up webinar in July once more things unfold in this dynamically changing world. We wanna be your source of thought leadership. Please do check us out next week if you're if you're able to join our, walk through the workflow. We would love to see you here again, very soon. Alright. Thanks, everyone. Have a wonderful day, and we'll be in touch soon. Thank you.